APC drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| CD11b | associated_with | APC | — | 1 |
| PTPRC | associated_with | APC | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations. (2020)
- Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
- Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. (2018)
- The genomic landscape of hypodiploid acute lymphoblastic leukemia. (2013)
- Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. (2011)
- Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. (2010)
- Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. (2009)
- Mechanism of alcohol-induced oxidative stress and neuronal injury. (2008)
- The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. (2007)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| apc | drug | 10 | 11 |